Predictive Biomarkers Market: A Deep Dive into the Industry's Key Applications and Technologies
The report aims to offers a thorough outlook of the Predictive Biomarkers Market based on various key elements, such as market drivers, limitations, threats, restraining factors, and growth prospects. The report aims to deliver a comprehensive understanding of the Predictive Biomarkers Market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline
The global predictive biomarkers market is expected to register a revenue CAGR during the forecast period. Increase in number of clinical trials is a key factor driving market revenue growth during the forecast period. In addition, developments and advancements in this field are expanding. Approximately, 427,086 clinical studies are currently under trial globally. Predictive biomarkers are also utilized to identify patients who will benefit from adjuvant radio- and or chemotherapy. Predictive biomarkers can help with patient care decisions like choosing between different interventions or figuring out which patients would benefit from a particular treatment. For instance, Kirsten Ras (KRAS) is a frequently mutated oncogene in colorectal cancer and a predictive biomarker for Epidermal Growth Factor (anti-EGFR) monoclonal antibody therapy resistance. According to MD Anderson Cancer, KRAS mutations are among the most prevalent gene mutations associated with cancer, found in about 25% of malignancies.
Get Free Exclusive Sample PDF Copy @ https://www.emergenresearch.com/request-sample/261